***This page is no longer active*** Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs through internal development and external collaborations and other arrangements. They used the MolecularBreeding™ directed evolution technology platform, along with ancillary technologies, and extensive protein modification expertise to pursue the creation of biosuperior proteins. Maxygen Inc. was dissolved in 2013. Visit the active Maxygen page at linkedin.com/company/maxygenllc
View Top Employees from MaxygenWebsite | http://www.maxygen.com |
Revenue | $6 million |
Employees | 50 (50 on RocketReach) |
Founded | 1996 |
Address | 725 San Aleso Ave, Sunnyvale, California 94085, US |
Phone | (650) 298-5300 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Web Rank | 16 Million |
Keywords | Maxygen Biotech Inc |
Competitors | Abmaxis, AtheroGenics , Inc., Genelabs Technologies, Orphazyme A/S, Pharming Group N.V. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Maxygen employee's phone or email?
The Maxygen annual revenue was $6 million in 2024.
Robert Whalen is the Chief Scientific Officer of Maxygen.
50 people are employed at Maxygen.
Maxygen is based in Sunnyvale, California.
The NAICS codes for Maxygen are [541, 54, 54171, 541714, 5417].
The SIC codes for Maxygen are [873, 87].